863609-11-4 Usage
Chemical class
Triazole derivative
Explanation
The compound belongs to the triazole class of chemicals, which are known for their diverse biological activities.
Explanation
The compound is a methyl ester derivative, which enhances its solubility and bioavailability.
Explanation
Triazoles, in general, are known for their diverse biological activities, which include antimicrobial, antifungal, and anticancer properties.
Explanation
The enhanced solubility and bioavailability of the methyl ester form make it potentially useful for the development of pharmaceutical products.
Explanation
The presence of the 3-chloro-phenyl group attached to the triazole ring may improve the compound's pharmacological properties, making it more effective for medical applications.
Explanation
Additional research and development of this compound could lead to the creation of new pharmaceutical products for a variety of medical applications.
Structure
Methyl ester derivative of 1-(3-chloro-phenyl)-1H-[1,2,4]-triazole-3-carboxylic acid
Biological activities
Antimicrobial, antifungal, and anticancer properties
Pharmaceutical applications
Potential use in drug development
3-chloro-phenyl group
Potential enhancement of pharmacological properties
Research and development
Further investigation needed for novel pharmaceutical products
Check Digit Verification of cas no
The CAS Registry Mumber 863609-11-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,3,6,0 and 9 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 863609-11:
(8*8)+(7*6)+(6*3)+(5*6)+(4*0)+(3*9)+(2*1)+(1*1)=184
184 % 10 = 4
So 863609-11-4 is a valid CAS Registry Number.
863609-11-4Relevant articles and documents
Monoacylglycerol Lipase Modulators
-
Paragraph 0410; 0525, (2020/04/24)
Bridged compounds of Formula (I) and Formula (II), pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with MGL modulation, such as those associated with pain, psychiatric disorders, neurological disorders (including, but not limited to major depressive disorder, treatment resistant depression, anxious depression, bipolar disorder), cancers and eye conditions. wherein R2, R3 R4, R5 and R6 are defined herein.
PIPERAZINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLU5 RECEPTORS
-
Page/Page column 53, (2013/07/05)
This invention relates to compounds of formula (I) their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. R1, R2, R3, R4, Q have meanings given in the description.
TRIAZOLE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS
-
Page/Page column 45-46, (2010/02/13)
The present invention relates to new compounds of formula (I), wherein P, Q, X1, X2, X3, X4 X7, X8, R1, R2, R3, m, n, and p are as defined as in formula (I)
